Background Acromegaly is a rare disease caused by an excess of growth hormone and insulin-like growth factor 1. It is usually diagnosed because of typical signs such as macroglossia, acral enlargement, jaw prognathism and malocclusion. Systemic complications are a major cause of morbidity and mortality in acromegaly, and many patients remain undiagnosed for several years. Increased ultrasound (US) application in the general population, and including among acromegaly patients, has revealed many suggestive features which, taken together with clinical suspicion, could induce suspicion of this disease. Purpose This review describes main US features in acromegaly. Echocardiography shows a typical cardiomyopathy, characterized by left ventricular hypertrophy, diastolic and systolic dysfunction, aortic and mitral regurgitation, and increased aortic root diameters. US preclinical markers of atherosclerosis, such as intima media thickness (IMT), seem also to be impaired. Visceromegaly and increased organ stiffness are other features of acromegaly, including enlarged prostate, kidneys, liver, and thyroid. In addition, other US findings are: renal cysts, micronephrolithiasis, impairment of renal haemodynamic parameters, gallstones and gallbladder polyps, hepatic steatosis, thyroid nodules, multinodular goiter, and polycystic ovaries. Musculoskeletal US findings are increased cartilage thickness, impaired density and elasticity of bones, nerve enlargement, carpal and cubital tunnel syndrome, and trigger finger. Conclusions Acromegaly patients frequently present systemic complications and a diagnostic delay. US features of acromegaly are not specific, but could potentially have a key role in early detection of the disease in the presence of typical clinical features.
Introduction
Acromegaly is a rare chronic disease caused by an excessive secretion of growth hormone (GH) and, consequently, of the hepatic production of insulin-like growth factor (IGF-I). In over 98% of the cases, it is caused by a GH-secreting pituitary adenoma [1] . Prolonged exposure to excess GH and IGF-I is responsible for the increased risk of insulin resistance, diabetes mellitus, dyslipidaemia, hypertension, and sleep apnea among these patients [2] . There are essentially three treatment options available: surgical intervention, medical therapy (with somatostatin analogues-octreotide, lanreotide and pasireotide; GH receptor analogue-pegvisomant; and dopamine agonists-cabergoline), and radiotherapy [3] . Acromegaly therapy aims to normalize GH and IGF-I levels, control tumor growth, improve the symptoms and quality of life of these patients, and improve or prevent systemic complications [4, 5] . In the past, cardiovascular complications were described as the main cause of death in acromegaly [5] , but recently, some studies, have shown that acromegaly patients have the same cardiovascular mortality risk as the general population, with neoplasms as the main cause of death [6, 7] .
Acromegaly is visually suspected at a glance by a clinician because of typical features caused by excess GH/IGF-1, however, many patients remain undiagnosed for many years. Macroglossia, jaw prognathism and malocclusion, acral enlargement (especially hands and feet), and soft tissue swelling are the most common visible abnormalities [1] . Due to these signs, it seems that acromegaly is mostly suspected by internists or general practitioners, neurosurgeons, neurologists, dentists, and endocrinologists; whereas radiologists and sonographers do not often make an acromegaly diagnosis [8] .
On the other hand, owing to the proliferative and antiapoptotic actions of GH/IGF-1, and to the whole pathophysiological picture, visceromegaly is another feature of acromegaly [1] . Enlarged thyroid, liver, kidney, prostate, and bi-ventricular hypertrophic cardiomyopathy are common findings in acromegaly [6, [9] [10] [11] [12] [13] [14] . In addition, polycystic ovaries and osteoarthritis have also been described [1, 15, 16] .
Modern medicine has been revolutionized by the use of ultrasound (US), thanks to its rapidity of execution, noninvasiveness, repeatability, cost-effectiveness, and absence of radiation. Acromegaly complications can be properly viewed with US and many patients likely have undergone US before the diagnosis of acromegaly. In addition, acromegaly guidelines suggest US for first approach to many systemic complications [4, 17, 18] .
We aimed to give an overview of US application in the management of acromegaly. In addition to being part of routine follow-up, US could be used as a potential tool for the diagnosis of acromegaly when combined with visible somatic features, giving the sonographer a potential role in the diagnosis of this rare disease.
All the main features described in this review are summarized in Fig. 1 , which compares clinical and US findings in acromegaly, and in Table 1 , which includes guidelines and consensus statement recommendations for acromegaly complications at screening and follow-up.
Cardiomyopathy affects approximately two-thirds of acromegaly patients (ACRO); it is frequently characterized by bi-ventricular hypertrophy, and diastolic and valvular dysfunction. The main cardiac histological characteristics are interstitial fibrosis and architectural subversion of the myocardium [19] . If this condition is not adequately and promptly treated, it is associated with an increased incidence of malignant arrhythmias, congestive heart failure, and sudden death [6, 20, 21] . The diagnosis of cardiomyopathy is based on the echocardiographic examination, recommended by the current international guidelines and consensus [18] . Recently, some studies have reviewed acromegaly cardiomyopathy, questioning the actual alterations that the heart undergoes. Popielarz-Grygalewicz et al. showed that, compared to 52 healthy controls, 140 ACRO had a significant increase in myocardial thickness, atrial volume, and mass of the left ventricle, with a slight reduction in diastolic function, which was not labeled as dysfunction. However, there were no significant differences in the size of the ventricles [6, 9] . Nevertheless, in past studies, cardiac ultrasonography showed signs of left ventricular hypertrophy (LVH) in 11-78% of patients [6] and diastolic dysfunction, evidenced by inadequate filling capacity, in 11-58% of patients [6] . Evident systolic dysfunction seems to be uncommon in ACRO [22, 23] , but Di Bello et al. reported an impaired myocardial strain in ACRO (strain indicates the end-systolic and end-diastolic difference of myocardial fiber length), which could indicate a subclinical systolic dysfunction [24] . On the other hand, these results were not confirmed by Volschan et al., who did not reveal strain impairment [25] . The end stage of acromegaly cardiomyopathy is characterized by ventricular dilatation with systolic dysfunction [26, 27] . This is a rare condition, but some cases have been reported in the literature, including in some younger patients [28, 29] . Dargat et al. described the case of a 41-year-old ACRO: she was given a tardive diagnosis of acromegaly, and, at initial evaluations, she was already presenting with signs of heart failure. An echocardiogram showed dilated ventricles with severe systolic and diastolic dysfunction [29] .
Valvulopathy is another echocardiographic finding described in acromegaly. Many authors have hypothesized that this abnormality is due to the fibrotic effect of GHexcess at the cardiac valvular levels with consecutive regurgitation [30] . Aortic and mitral are the most affected valves. Pereira et al. compared 40 ACRO to 120 matched controls, and reported aortic regurgitation in 30% of ACRO and 7% of controls (p < 0.001) and mitral regurgitation in 5% of ACRO and 0% of controls (p = 0.014) [31] . The same group found an association between GH levels and the progression of valvulopathy [32] .
Aortic root diameters have been found to be increased in 37 ACRO compared to 37 matched controls (p = 0.006) by Pereira et al., independent of hormonal levels or disease activity [33] . They also found that during a mean follow-up of 1.9 years, the aortic root diameters increased in ACRO (p = 0.025), without correlation to disease activity. No thoracic aneurisms were detected [33] .
Recently, Tona et al. analyzed the coronary flow reserve by measuring left anterior descending coronary artery velocity (as a marker of coronary microvascular function) in 40 ACRO compared to 40 controls. They found a significant impairment of coronary microvascular flow among ACRO, compared to controls (p < 0.0001), that was improved by therapy with somatostatin analogues. IGF-1 was also associated with the degree of dysfunction (p < 0.0001). These results are evidence of coronary microcirculation dysfunction, suggesting higher cardiovascular risk [34] .
Functional cardiac impairment in ACRO is still a matter of debate, and Gadhela et al. hypothesized that the hypertrophy induced by GH and IGF-1 could be mitigated by their concomitant inotropic effect. Nevertheless, echocardiogram is recommended by the guidelines as a screening measure of morphological and functional complications, in particular, if cardiac involvement is suspected [4, 17, 18] . A recent consensus on acromegaly complications recommended annual execution of echocardiogram, especially in gigantism [18] .
Preclinical markers of atherosclerosis
The highly debated issue of cardiovascular risk among ACRO has been well described in the literature [1, 5, 6] . The key point to discuss here is whether US could be a good instrument to detect preclinical markers that can predict cardiovascular risk. Parolin et al. recently completed a meta-analysis on studies regarding three ultrasonographic preclinical markers of atherosclerosis: carotid intima media thickness (IMT), pulse wave velocity (PWV), and flow-mediated dilation (FMD) [35] . Abnormalities in these measures have been associated with increased cardiovascular risk in the general population [36] [37] [38] . In this metaanalysis, the authors showed ACRO were impaired in all three of these measures as compared to controls (p = 0.001, p < 0.0001 and p = 0.0001, respectively). Additionally, IMT and FMD were influenced by disease activity (p = 0.041 and p = 0.038, respectively) [35] . These data would indicate a high risk of cardiovascular disease in acromegaly, as stated in the past [1, 5, 7] . However, as aforementioned, recent large studies have not shown a higher risk of cardiovascular mortality in acromegaly [6, 7, 39] and a recent consensus statement suggests that annual echo Doppler of peripheral arterial and venous system would be prudent in ACRO [18] .
Prostate
Prostate hyperplasia, predominantly mild hyperplasia, has been described in ACRO younger than 50 years. Kumar et al. compared 53 ACRO to 50 matched controls, and found a significantly higher International Prostate Symptom Score (3.9 ± 3.5 vs 0.5 ± 0.2; p = 0.001) and prostatic volume (21.7 ± 8.7 vs 12.5 ± 3.7; p = 0.001) among ACRO [14] . Colao et al. reported that disease control obtained with specific treatment for acromegaly was significantly associated with a reduction in prostate volume (p = 0.030) [40] .
Other authors have shown a higher incidence of prostatic structural alteration, such as cysts, nodules, and calcifications [41] . However, a recent meta-analysis documented that prevalence of prostate cancer seems to be just slightly or not significantly elevated, with a standardized incidence ratio of 1.2 in ACRO compared to general population [42] . For these reasons, many experts suggest the same screening approach to prostate pathology in ACRO as in general population [11] .
Kidney
Renal involvement has been documented in ACRO. Yamamoto et al. studied the prevalence of renal cysts in 71 ACRO who underwent routine abdominal US. Approximately one-third (32.4%) of ACRO had at least one cyst, and their presence was significantly correlated with smoking status, older age, and nadir GH during OGTT (oral glucose tolerance test, the sample measure used for the diagnosis of acromegaly) [4] . The study did not include a control group, but the authors stated that the prevalence of renal cysts in the general population from the same area was from 4.2 to 10.7%. In addition, the authors suggested, because of the relationship between cystic renal disease hypertension and kidney dysfunction, clinicians should pay attention to renal cysts detected in ACRO [43] . Kidney stones were studied in 58 ACRO compared to 30 subjects by Auriemma et al. [44] . They found that ACRO had larger renal size with respect to controls, with larger longitudinal (p < 0.05) and transverse (p < 0.05) diameters. In addition, they reported a higher prevalence of micronephrolithiasis (p < 0.001). Active ACRO also had higher levels of urinary calcium (p < 0.001) and phosphorus (p < 0.01), accompanied by hypercitraturia (p < 0.05) and hyperoxaluria (p < 0.001). The first three types of mineral were also significantly influenced by disease activity. Microalbuminuria was also higher in ACRO (p < 0.05). The authors also found that the previous structural and functional alterations were only partially reversed by therapy, thus they hypothesized that some changes are irreversible [44] .
Serious kidney involvement could be circumspect of acromegaly, in particular recurrent nephrolithiasis. Van [45] . In a recent study, Bankir et al. evaluated tissue elasticity in 40 ACRO compared to 20 healthy controls using share wave elastography (a non-invasive method that can give a quantitative measure of tissue elasticity), in organ size. With respect to the kidney, they found significantly larger size, and cortical thickness and stiffness in active ACRO compared to controls (p < 0.001, p = 0.021 and p < 0.001, respectively) [10] . They additionally found an independent association between organ stiffness and IGF-1 (p < 0.001), and speculated that this could be related to IGF-1 stimulation in collagen and protein synthesis [10] .
Renal hemodynamic parameters seem to be impaired by acromegaly, too. In 57 newly diagnosed ACRO, hypertension was detected in 16 (28.1%) patients. Renal resistive index (RRI), an index that can reveal vascular and functional kidney abnormalities, was found to be higher in hypertensive compared to normotensive patients (p = 0.001), and, in regression analysis, IGF-1 was found to be independently associated with RRI [45] . Since RRI could be a preclinical index of hypertension and could be an early sign of hypertension development, renal Doppler US could be a useful exam in ACRO, especially given its non-invasive and costeffective nature.
Biliary system
Acromegaly seems to be associated with a higher risk of cholelithiasis. Montini et al. performed an US exam in 49 ACRO at baseline and then every 6 months during octreotide therapy. Gallbladder stones were found in 26.5% of patients at baseline. They did not include a control group, but compared their results to the Italian general population, and found that women (18.9%) were more likely to have gallbladder stones than men (9.5%). During octreotide therapy, gallstones developed in 19.0% of patients [46] . Additionally, ACRO are at risk of developing gallbladder polyps. In a study by Annamalai et al., biliary US was performed in 31 newly diagnosed acromegalies and compared, retrospectively, to US in 13,234 non-ACRO. They found a prevalence of gallbladder polyps in 29.0% ACRO compared to 4.62% of control subjects (odds ratio (OR) = 8.45, p < 0.001). Moreover, they found a positive correlation between GH values and presence of gallbladder stones (p = 0.014). Despite the previous findings, clinical significance of gallstones appears to be low [47] . For these reasons, actual guidelines recommend that biliary US should be performed only in ACRO that report biliary symptoms, especially during somatostatin analogues treatment [4, 29] .
Liver
In ACRO, the liver seems to be enlarged compared to the general population [1, 10] . At present, GH-excess effect on adipose deposition in the liver is not clear. It is unknown whether acromegaly predisposes or prevents hepatic accumulation of fat since the pathophysiological network regulation is complex and not fully understood [48, 49] . Among a sample of 19 newly diagnosed ACRO, Ciresi et al. reported that 61.0% had hepatic steatosis, with no improvement after 12 months of therapy with octreotide (control of the disease was reached in 58%) [50] . Conversely, they reported a significant improvement in the hepatic steatosis index with therapy (p < 0.001) [50] . Hepatic steatosis index is calculated based on biomarkers AST, ALT, and BMI. It significantly correlates with the presence and degree of the steatosis [51] . In addition, other studies have reported that ACRO have significantly larger (p < 0.001), more echogenic (p = 0.021), and stiffer (using share wave elastography, previously mentioned in the kidney section) (p = 0.001) livers compared to controls [10] . The authors also found that liver stiffness was significantly associated with IGF-1 (p < 0.001), and hypothesized that this could be due to collagen and protein synthesis induced by IGF-1 [10] . Based on these findings, we hypothesize that lipid deposition of fat is modest in acromegaly and it is improved by therapy, but it does not seem to be effectively detected by US [50] . Notably, US has poor sensitivity in detecting less than 20% fatty involvement of the liver [52] . Further studies are necessary, and the actual guidelines do not recommend routine liver US in ACRO [4, 18] .
Thyroid
Thyroid nodules in acromegaly have been largely described in the literature, with a wide range of results [11, 12, 18] . In contrast to the general population [53] , in acromegaly, men and women do not differ in thyroid nodule prevalence [12, 13] . Wolinski et al. compared 205 ACRO to 184 matched controls and found thyroid lesions and multinodular goiters, respectively, in 77.6% and 66.8% of ACRO, and 63.0% and 47.8% of controls (p = 0.002; p = 0.0002). Thyroid dimensions were larger in ACRO, but no significant difference was found in cancer prevalence [54] . The same group also performed a meta-analysis and found ACRO had a significantly higher risk of thyroid lesions (OR = 3.3, p < 0.001) and cancer (OR = 3.9, p < 0.001). These results have been confirmed by a meta-analysis by Dal et al., which found a standardized incidence ratio for thyroid lesions of 9.2 among ACRO [42] . The presence, dimensions, and evolution of nodules seems to be influenced by disease activity [11] . Dogansen et al. considered thyroid US follow-up in 138 ACRO, finding that the presence (p = 0.010) and growth (p = 0.030) of nodules was significantly associated with disease activity [55] . In recent decades, the prevalence of thyroid cancer in ACRO has increased, but it could be due to an uptick in diagnosis linked to increased US screening [6, 11] . Importantly, the mortality rate for thyroid carcinoma remains low [11] . Bankir et al. found that ACRO also have larger (p = 0.003), and more echogenic (p = 0.014) and elastographic (p = 0.012) thyroids, compared to controls [10] . Despite these findings, while many authors suggest routine US [56] , actual guidelines recommend US only if a thyroid nodule is palpable [4] and many authors agree with this approach [6] .
Arthropathy-bone disease
In addition to visceromegaly, arthropathy is another common comorbidity in acromegaly, and is an important cause of morbidity [1] . Arthropathy is determined by GH/IGF-1-induced hypertrophy of cartilage, tendons, ligaments, and nerves, and it is classically studied with radiographs, which joint space widening. Fonseca et al. reported a case of a 41-year-old ACRO. Using musculoskeletal US, they detected increased anechogenic cartilage thickness of metacarpophalangeal joints and knees, small osteophytes in knee articulation that were poorly evidenced by radiographs, an enlarged nerve bundle, and, finally, increased fat pad of plantar fascia [57] . These results agree with studies that found increased ligament thickness in ACRO, which, in many cases, is reversed by disease control secondary to the acromegaly therapy [6, 58, 59] . US application in this field has not been extensively studied in ACRO, but the previous elements suggest that it could be a very useful instrument to study arthropathy in acromegaly.
Osteoporosis is another common complication in acromegaly [1] . However, pathogenesis of secondary osteoporosis in acromegaly is still unclear. Cortical bone mineral density in ACRO is increased, while trabecular bone mineral density is decreased, despite the high anabolic effect of GH and IGF-1 [60] [61] [62] . Classically, osteoporosis is diagnosed by DEXA, but some studies have suggested that it may be possible to assess bone structure properties in ACRO [63] . Bolanowski et al. studied quantitative US indices of heels (this method had been proposed for osteoporosis screening in general population and the accuracy is similar to DEXA)-they did not find differences between 26 ACRO and 20 controls [62] . US attenuation, speed of sound, and the stiffness index were higher in active ACRO than controlled ACRO (p = 0.011, p = 0.015 and p = 0.008, respectively), and, in male patients, speed of sound and US attenuation were inversely correlated with GH (p = 0.002 and p = 0.0001, respectively). This correlation was not found among women. The authors speculated that these results could indicate density and elasticity alterations in bone of active ACRO [63] , but, at the moment, there is not sufficient evidence to suggest bone US as a screening for osteoporosis in ACRO.
Musculoskeletal complications
Nerve enlargement has been described in ACRO. [64] . These results seem to be confirmed by recent studies involving magnetic resonance imaging in the study of carpal tunnel among ACRO [65] .
From early studies, bilateral carpal syndrome has been described as a common complication of acromegaly [1] , but its pathogenesis is still debated. Some studies have identified median nerve enlargement as the principal cause of this complication. Tagliafico et al. demonstrated that in 34 ACRO, there was a significant enlargement of median and ulnar nerves along their whole lengths, not just at the carpal tunnel site (the results were compared to 34 matched controls, p < 0.001) [66] . Therefore, the authors speculated that carpal tunnel syndrome in acromegaly is derived from intrinsic median nerve enlargement, despite a narrowing of the tunnel itself. This is confirmed by the reported unsuccessful surgical treatment in many ACRO [66, 67] .
The compression of the ulnar nerve at the elbow, defined as cubital tunnel syndrome [68] , is another musculoskeletal complication described in acromegaly [67] , and, similar to carpal tunnel syndrome, the pathogenesis seems to be the significantly larger area of the ulnar nerve in ACRO [64, 67] .
Finally, trigger finger (a transient block of the fingers in the flexed position due to the thickening of the A1 pulley that surround flexor tendons above metacarpophalangeal joint) [27] has been reported in 25% ACRO, and a greater thickness of A1 pulley in ACRO respect to 40 matched controls was found [69] .
Polycystic ovary syndrome (PCOS) and acromegaly
The association between acromegaly and polycystic ovarian syndrome is still a debated issue. GH/IGF-1 excess induces gonadal dysfunction, and some studies have reported menstrual abnormalities, hirsutism, and polycystic ovaries [70, 71] . In the literature, there are some case reports about diagnosis of acromegaly suspected because of persistent hyperandrogenism and polycystic ovarian features [15, 16] , with a possible reversible ovarian picture, in some cases, after disease control [16] . In two case series by Grynberg et al. and Kaltsas et al., a PCOS-like phenotype was found in, respectively, 12% and 43% of female ACRO [70, 72] . In addition, IGF-1 is correlated with a larger mean ovarian volume (r = 0.851, p < 0.05). For these reasons, many authors suggest including acromegaly in the differential diagnosis of rare causes of hyperandrogenism and PCOS-like pictures [73, 74] . However, actual guidelines do not recommend a gynecological US in ACRO at diagnosis.
Breast/spleen
Briefly, many reports have not found an increased prevalence of breast cancer in acromegaly, so more rigorous screening in ACRO is not recommended [6, 11] . Additionally, the spleen is not enlarged in acromegaly, and some authors have interpreted splenomegaly as the presence of a second pathology [75] [76] [77] .
A focus on veterinary ultrasound: feline acromegaly
Acromegaly is not just a human condition. Feline acromegaly has been widely described in the veterinary literature [78] . Feline acromegaly is mainly caused by a GH-secreting adenoma or hyperplasia in the pituitary gland. Main pathophysiological and clinical characteristics are enlargement of the jaw, extremities and skull, diabetes mellitus, cardiomyopathy [79] , and visceromegaly [78] . Lourenco et al. [80] compared ultrasonographic features of 24 ACRO cats and 24 non-ACRO control cats. They found renal, pancreatic, and adrenal enlargement among ACRO cats (p < 0.001, p = 0.003 and p < 0.001, respectively), with more frequent bilateral adrenomegaly in ACRO cats (p < 0.001). In addition, ACRO cats had a higher prevalence of morphological abnormalities. The pancreas was more hypoechoic, presented with more nodules or cysts (p < 0.001), and the liver was bigger (p < 0.001) and had more abnormalities in terms of echogenicity, echotexture, and presence of nodules or cysts (p < 0.001) [80] . The previous study offers an interesting consideration. In felines, acromegaly is a challenging diagnosis. Poorly controlled diabetes mellitus is often the first presentation of feline acromegaly [78] and US is a very common exam prescribed in this clinical setting. For these reasons, researchers have attempted to construct a comprehensive picture of suggestive findings to suspect acromegaly [80] .
Conclusions
In several instances, acromegaly is obscured in poly-pathological patients and a patient could be seen by many specialists before receiving the correct diagnosis. A sonographer could be one of the first clinicians to perform a diagnostic evaluation of systemic complications in a patient still unknown to be affected by acromegaly. Many of the ultrasonographic findings described in this review are not specific to acromegaly (e.g. renal cysts, nodular thyroid disease), similar to many of its clinical features (e.g., diabetes mellitus, hypertension, obstructive sleep apnea syndrome). Nevertheless, the expert sonographer could play a key role in diagnosis of acromegaly through the detection of a combination of echographic alterations and typical clinical findings, giving the patient the possibility of an earlier diagnosis and appropriate therapy.
